Literature DB >> 2106757

Parenteral iron dextran therapy.

V J Kumpf1, E G Holland.   

Abstract

Parenteral iron therapy is indicated in patients with iron-deficiency anemia associated with conditions that interfere with the ingestion or absorption of oral iron. Replacement doses of iron required to replenish iron stores are based on body weight and the observed hemoglobin value. Methods of administering iron dextran are reviewed, including intramuscular and intravenous injections of the undiluted drug, intravenous infusion of a diluted preparation, and as an addition to parenteral nutrition solutions. The overall incidence of adverse reactions associated with the parenteral administration of iron is low, but the potential for an anaphylactic reaction requires that an initial test dose be given followed by careful patient observation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106757     DOI: 10.1177/106002809002400210

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  2 in total

Review 1.  Safety aspects of parenteral iron in patients with end-stage renal disease.

Authors:  G Sunder-Plassmann; W H Hörl
Journal:  Drug Saf       Date:  1997-10       Impact factor: 5.606

2.  Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study.

Authors:  Harold J Manley; Darren W Grabe
Journal:  BMC Nephrol       Date:  2004-01-12       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.